These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 25717252

  • 1. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.
    Inada R, Sekine S, Taniguchi H, Tsuda H, Katai H, Fujiwara T, Kushima R.
    World J Gastroenterol; 2015 Feb 21; 21(7):2159-68. PubMed ID: 25717252
    [Abstract] [Full Text] [Related]

  • 2. Various ARID1A expression patterns and their clinical significance in gastric cancers.
    Kim YB, Ham IH, Hur H, Lee D.
    Hum Pathol; 2016 Mar 21; 49():61-70. PubMed ID: 26826411
    [Abstract] [Full Text] [Related]

  • 3. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T.
    J Clin Pathol; 2015 Oct 21; 68(10):795-801. PubMed ID: 26043748
    [Abstract] [Full Text] [Related]

  • 4. Loss of ARID1A expression is associated with DNA mismatch repair protein deficiency and favorable prognosis in advanced stage surgically resected esophageal adenocarcinoma.
    Lowenthal BM, Nason KS, Pennathur A, Luketich JD, Pai RK, Davison JM, Ma C.
    Hum Pathol; 2019 Dec 21; 94():1-10. PubMed ID: 31655170
    [Abstract] [Full Text] [Related]

  • 5. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
    Tang P, Huang H, Chang J, Zhao GF, Lu ML, Wang Y.
    World J Gastroenterol; 2013 May 07; 19(17):2697-703. PubMed ID: 23674878
    [Abstract] [Full Text] [Related]

  • 6. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
    Zhao P, Lu Y, Liu L.
    Int J Clin Exp Pathol; 2015 May 07; 8(5):5230-5. PubMed ID: 26191222
    [Abstract] [Full Text] [Related]

  • 7. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX, Ding L, Lin Y, Shu M, Wen JM, Xue L.
    J Clin Pathol; 2015 May 07; 68(5):374-80. PubMed ID: 25731189
    [Abstract] [Full Text] [Related]

  • 8. Switch/sucrose nonfermenting nucleosome complex-deficient colorectal carcinomas have distinct clinicopathologic features.
    Villatoro TM, Ma C, Pai RK.
    Hum Pathol; 2020 May 07; 99():53-61. PubMed ID: 32222462
    [Abstract] [Full Text] [Related]

  • 9. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
    Zhang L, Qiu M, Jin Y, Ji J, Li B, Wang X, Yan S, Xu R, Yang D.
    Int J Clin Exp Pathol; 2015 May 07; 8(9):11084-91. PubMed ID: 26617827
    [Abstract] [Full Text] [Related]

  • 10. ARID1A expression in early stage colorectal adenocarcinoma: an exploration of its prognostic significance.
    Lee LH, Sadot E, Ivelja S, Vakiani E, Hechtman JF, Sevinsky CJ, Klimstra DS, Ginty F, Shia J.
    Hum Pathol; 2016 Jul 07; 53():97-104. PubMed ID: 26980037
    [Abstract] [Full Text] [Related]

  • 11. ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts.
    Wiegand KC, Sy K, Kalloger SE, Li-Chang H, Woods R, Kumar A, Streutker CJ, Hafezi-Bakhtiari S, Zhou C, Lim HJ, Huntsman DG, Clarke B, Schaeffer DF.
    Hum Pathol; 2014 Jun 07; 45(6):1258-68. PubMed ID: 24767857
    [Abstract] [Full Text] [Related]

  • 12. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR, Sun Z, Zhu Z, Guan HX, Li CY, Zhang JY, Zhang YN, Zhou H, Zhang HJ, Xu HM, Sun MJ.
    World J Gastroenterol; 2015 May 07; 21(17):5336-44. PubMed ID: 25954108
    [Abstract] [Full Text] [Related]

  • 13. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
    Xu CC, Yue L, Wei HJ, Zhao WW, Sui AH, Wang XM, Qiu WS.
    Pathol Res Pract; 2013 Aug 07; 209(8):479-85. PubMed ID: 23822993
    [Abstract] [Full Text] [Related]

  • 14. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
    González I, Goyal B, Xia MD, Pai RK, Ma C.
    Hum Pathol; 2019 Mar 07; 85():18-26. PubMed ID: 30381262
    [Abstract] [Full Text] [Related]

  • 15. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
    Hu X, Huang Z, Liao Z, He C, Fang X.
    Int J Clin Exp Pathol; 2014 Mar 07; 7(10):6716-24. PubMed ID: 25400751
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of HER-2 Protein is a High-Risk Factor for Patients with Surgically-Resected Stage T3 Gastric Adenocarcinoma.
    Zhang Z, Wang B, Huang G, Wang R, Song J, Lin S, Wang W, Jiang Y, Huang Q, Wang L.
    Clin Lab; 2017 Jan 01; 63(1):115-125. PubMed ID: 28164509
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.
    Jin EH, Lee DH, Jung SA, Shim KN, Seo JY, Kim N, Shin CM, Yoon H, Jung HC.
    World J Gastroenterol; 2015 Jan 14; 21(2):571-7. PubMed ID: 25593477
    [Abstract] [Full Text] [Related]

  • 18. Increased MACC1 expression indicates a poor prognosis independent of MET expression in gastric adenocarcinoma.
    Koh YW, Hur H, Lee D.
    Pathol Res Pract; 2016 Feb 14; 212(2):93-100. PubMed ID: 26719224
    [Abstract] [Full Text] [Related]

  • 19. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB, Xu Y, Chen LG, Guan TP, Ma YY, He XJ, Xia YJ, Tao HQ, Shao QS.
    Eur J Surg Oncol; 2014 Mar 14; 40(3):318-24. PubMed ID: 24406159
    [Abstract] [Full Text] [Related]

  • 20. Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patients.
    Tober JM, Halske C, Behrens HM, Krüger S, Röcken C.
    Hum Pathol; 2019 Dec 14; 94():98-109. PubMed ID: 31704366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.